These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 16731022)

  • 21. Psychotic and compulsive symptoms in Parkinson's disease.
    Verbaan D; van Rooden SM; Visser M; Marinus J; Emre M; van Hilten JJ
    Mov Disord; 2009 Apr; 24(5):738-44. PubMed ID: 19133665
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Severe cervical dystonia in pathologically proven Parkinson's disease and dementia.
    Cohen O; Fahn S; Frucht SJ
    Mov Disord; 2003 Nov; 18(11):1381-2. PubMed ID: 14639686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life.
    Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR
    Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Parkinsonism following dystonia in three patients.
    Katchen M; Duvoisin RC
    Mov Disord; 1986; 1(2):151-7. PubMed ID: 3504239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Early morning dystonia: a complication of levodopa therapy in Parkinson disease. Presentation of 4 cases].
    Molina Arjona JA; Arnal García C; Calandre Hoenigsfeld L; Bermejo Pareja F
    Med Clin (Barc); 1984 Jun; 83(2):47-9. PubMed ID: 6471944
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term Parkinson's disease--time for optimism.
    Yust-Katz S; Sthneer S; Melamed E; Djaldetti R
    Biomed Pharmacother; 2008; 62(4):233-5. PubMed ID: 18294809
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism.
    Paus S; Gadow F; Knapp M; Klein C; Klockgether T; Wüllner U
    Mov Disord; 2009 May; 24(7):1080-4. PubMed ID: 19353703
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the structure of motor symptoms of Parkinson's disease.
    Stochl J; Boomsma A; Ruzicka E; Brozova H; Blahus P
    Mov Disord; 2008 Jul; 23(9):1307-12. PubMed ID: 18464275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ropinirole-induced Pisa syndrome in Parkinson disease.
    Galati S; Möller JC; Städler C
    Clin Neuropharmacol; 2014; 37(2):58-9. PubMed ID: 24614668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lateral flexion in Parkinson's disease and Pisa syndrome.
    Yokochi F
    J Neurol; 2006 Dec; 253 Suppl 7():VII17-20. PubMed ID: 17131222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bilateral STN-DBS fails to improve non-motor fluctuations in a PD patient.
    Cersosimo MG; Piedimonte F; Raina GB; Micheli FE
    Parkinsonism Relat Disord; 2007 Dec; 13(8):537-8. PubMed ID: 17236805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Longitudinal study of the motor response to levodopa in Parkinson's disease.
    Clissold BG; McColl CD; Reardon KR; Shiff M; Kempster PA
    Mov Disord; 2006 Dec; 21(12):2116-21. PubMed ID: 17029259
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-duration response to levodopa in patients with advanced Parkinson disease treated with subthalamic deep brain stimulation.
    Wider C; Russmann H; Villemure JG; Robert B; Bogousslavsky J; Burkhard PR; Vingerhoets FJ
    Arch Neurol; 2006 Jul; 63(7):951-5. PubMed ID: 16831963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Forms of dystonia in patients with Parkinson's disease.
    Kidron D; Melamed E
    Neurology; 1987 Jun; 37(6):1009-11. PubMed ID: 3587617
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Continuous dopaminergic stimulation by Duodopa in advanced Parkinson's disease: Efficacy and safety].
    Annic A; Devos D; Seguy D; Dujardin K; Destée A; Defebvre L
    Rev Neurol (Paris); 2009; 165(8-9):718-27. PubMed ID: 19150100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations.
    Hauser RA; Shulman LM; Trugman JM; Roberts JW; Mori A; Ballerini R; Sussman NM;
    Mov Disord; 2008 Nov; 23(15):2177-85. PubMed ID: 18831530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duodenal levodopa infusion improves quality of life in advanced Parkinson's disease.
    Antonini A; Mancini F; Canesi M; Zangaglia R; Isaias IU; Manfredi L; Pacchetti C; Zibetti M; Natuzzi F; Lopiano L; Nappi G; Pezzoli G
    Neurodegener Dis; 2008; 5(3-4):244-6. PubMed ID: 18322402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetic and pharmacodynamic comparison of ropinirole 24-hour prolonged release and ropinirole immediate release in patients with Parkinson's disease.
    Tompson D; Oliver-Willwong R
    Clin Neuropharmacol; 2009; 32(3):140-8. PubMed ID: 18978485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
    Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K
    Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.